Symptoms are unpredictable, can make socializing difficult, and may increase feelings of anxiety and isolation1,7,8
Up to 20% of patients experience a myasthenic crisis at least once in their lives, which can cause fatal respiratory failure5,6
Symptoms are unpredictable, can make socializing difficult, and may increase feelings of anxiety and isolation1,7,8
Patients experienced an average of about 63 sick days, potentially leading to work productivity loss9*
84% of patients are concerned about potential long-term side effects of immunosuppressive therapy11‡
*Data from MyRealWorld-MG (December 2019-July 2023), a multinational observational study of 2,424 adult MG patients across 10 countries, which was aimed at assessing productivity loss by symptom severity. 1,049 of the patients studied reported their MG-ADL score as well as data on sick leave and/or their need for a caregiver. Inclusion required patients to be aged ≥18; those over 65 were excluded from productivity analyses. Patients self-reported their diagnosis in the MyRealWorld-MG smartphone application.9
†Data were collected from 41 patients with autoimmune MG using the Myasthenia Gravis Foundation of America classification system to analyze factors leading to unsatisfactory outcomes.10
‡Data from an online survey collected from 283 self-identified MG patients and 45 MG physician experts. The goal of the survey was to better define patient and physician opinions about gMG, long-term immunosuppressant exposure, and dose reduction to inform the potential design of a randomized clinical trial.10
gMG=generalized myasthenia gravis; MG=myasthenia gravis; MG-ADL=Myasthenia Gravis Activities of Daily Living.
—Real patient living with gMG
gMG=generalized myasthenia gravis.
A survey showed that patients (n=28) reported that the following effects of gMG persisted, despite being on current treatments12*:
*Data collected from a qualitative, cross-sectional, non-interventional study in 28 people who reported receiving at least one treatment for gMG, including AChEIs, steroids, or NSISTs. Eligible participants were US residents, ≥18 years old, and comfortable reading and communicating in English. Study excluded people with only ocular disease to better understand the breadth of MG symptoms that affect all muscle groups.12
AChEI=acetylcholinesterase inhibitor; AChR=acetylcholine receptor; gMG=generalized myasthenia gravis; MG=myasthenia gravis; NSIST=nonsteroidal immunosuppressive therapy.
References: 1. Twork S et al. Health Qual Life Outcomes. 2010;8:129. doi:10.1186/1477-7525-8-129 2. Boldingh MI et al. Health Qual Life Outcomes. 2015;13:115. doi:10.1186/s12955-015-0298-1 3. Eliasen A et al. J Neurol. 2018;265(6):1303-1309. doi:10.1007/s00415-018-8837-4 4. Chu HT et al. Front Psychiatry. 2019;10:481. doi:10.3389/fpsyt.2019.00481 5. Grob D et al. Muscle Nerve. 2008;37(2):141-149. doi:10.1002/mus.20950 6. Wendell LC, Levine JM. Neurohospitalist. 2011;1(1):16-22. doi:10.1177/1941875210382918 7. Howard JF Jr. Myasthenia Gravis: A Manual for the Health Care Provider. Myasthenia Gravis Foundation of America; 2009. 8. Suzuki Y et al. BMJ Open. 2011;1(2):e000313. doi:10.1136/bmjopen-2011-000313 9. Dewilde S et al. Front Public Health. 2025;13:1538789. doi:10.3389/fpubh.2025.1538789 10. Bacci ED et al. BMC Neurol. 2019;19(335). doi:10.1186/s12883-019-1573-2 11. Hehir MK et al. Muscle Nerve. 2020;61(6):767-772. doi:10.1002/mus.26850 12. Jackson K et al. Neurol Ther. 2023;12(1):107-128. doi:10.1007/s40120-022-00408-x
An argenx representative will contact you soon, so keep an eye on your inbox.
Receive information about gMG from argenx
An argenx representative will contact you soon, so keep an eye on your inbox.
Just a quick heads up—we're not responsible for verifying or maintaining information outside of this website
Search for: